Minerva Neurosciences, Inc.
NERV- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001598646
No open-market purchases or sales by Minerva Neurosciences, Inc. insiders were filed in the last 90 days; 61 institutions reported holding it in 13F filings for Q2 2026, worth $234.8M in total; no superinvestor holds it.
13F holders, Q1 2025
Institutional positions in Minerva Neurosciences, Inc. as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 22
- 0 vs. Q4 2024
- Shares held
- 1.95M
- −133.8K (−6.4%) vs. Q4 2024
- Total value
- $3.31M
- −$1.32M (−28.5%) vs. Q4 2024
- New holders
- 3
- 4 more added
- Sold out
- 3
- 4 more reduced
Compare with Q4 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting NERV on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 61 | $234.8M |
| Q1 2026 | 47 | $236.1M |
| Q4 2025 | 33 | $107.7M |
| Q3 2025 | 24 | $4.21M |
| Q2 2025 | 21 | $3.34M |
| Q1 2025 | 22 | $3.31M |
| Q4 2024 | 22 | $4.63M |
| Q3 2024 | 21 | $5.65M |
| Q2 2024 | 21 | $6.65M |
| Q1 2024 | 21 | $5.42M |
| Q4 2023 | 20 | $14.9M |
| Q3 2023 | 20 | $16.6M |
| Q2 2023 | 19 | $19.0M |
| Q1 2023 | 17 | $2.69M |
| Q4 2022 | 19 | $2.75M |
| Q3 2022 | 25 | $18.7M |
| Q2 2022 | 23 | $7.51M |
| Q1 2022 | 33 | $16.3M |
| Q4 2021 | 35 | $16.6M |
| Q3 2021 | 46 | $42.9M |
| Q2 2021 | 68 | $63.2M |
| Q1 2021 | 72 | $91.4M |
Institutions, Q1 2025
Shares, value and share of portfolio for each institution holding Minerva Neurosciences, Inc.; share changes are against Q4 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Federated Hermes, Inc. | 1,351,275 | $2.30M | 0.00% | 00.0% | Unchanged |
| Vanguard Group Inc | 252,060 | $428.5K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 114,097 | $194.0K | 0.00% | −14,003−10.9% | Reduced |
| Geode Capital Management, LLC | 76,732 | $130.5K | 0.00% | +20,276+35.9% | Added |
| BlackRock, Inc. | 72,669 | $123.5K | 0.00% | 00.0% | Unchanged |
| Acadian Asset Management LLC | 17,416 | $29.0K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 16,519 | $28.1K | 0.00% | 00.0% | Unchanged |
| Apella Capital, LLC | 20,625 | $27.6K | 0.00% | +20,625 | New |
| Citadel Advisors LLC | 12,915 | $22.0K | 0.00% | −12,849−49.9% | Reduced |
| Morgan Stanley | 11,004 | $18.7K | 0.00% | −5,100−31.7% | Reduced |
| Tower Research Capital LLC (TRC) | 2,643 | $4.49K | 0.00% | +1,201+83.3% | Added |
| Wells Fargo & Company | 1,938 | $3.29K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 1,621 | $2.76K | 0.00% | +1,609+13,408.3% | Added |
| Northwestern Mutual Wealth Management Co | 100 | $170 | 0.00% | 00.0% | Unchanged |
| Farther Finance Advisors, LLC | 100 | $155 | 0.00% | +100 | New |
| BNP Paribas Arbitrage, SA | 62 | $105 | 0.00% | 00.0% | Unchanged |
| SBI Securities Co., Ltd. | 53 | $90 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 46 | $78 | 0.00% | +1+2.2% | Added |
| FMR LLC | 25 | $43 | 0.00% | +25 | New |
| JPMorgan Chase & Co | 17 | $29 | 0.00% | 00.0% | Unchanged |
| Anchor Investment Management, LLC | 12 | $20 | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 152 | $0 | 0.00% | −1,393−90.2% | Reduced |
| UBS Oconnor LLC | 0 | $0 | 0.00% | −107,256−100.0% | Sold out |
| Northern Trust Corp | 0 | $0 | 0.00% | −36,878−100.0% | Sold out |
| TFC Financial Management | 0 | $0 | 0.00% | −186−100.0% | Sold out |